Definitive Contract HHSF223201610110C
Award Date 9/9/16
Potential Completion Date 3/30/19
Potential Value $306K
Federal Agency
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
France
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
68
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $119,900 firm-fixed-price definitive contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Institut National De La Sante Et De La Recherche Medicale, registered as ADM Deleguee Reg Parisnord Paris 7, a foreign government entity structured as the country of France. The contract is for conducting Pharmacokinetic (PK) studies. There is no set-aside designation on this award. This contract appears to be a standalone award, not...
- The Department of Health and Human Services' Food and Drug Administration awarded a Firm Fixed Price Definitive Contract to Uppsala Universitet, an educational institution, for the evaluation and development of model-based bioequivalence analysis strategies. The $574,726.00 contract, which does not have a set-aside designation, was awarded on April 10, 2017 with a completion date of September 1, 2020. The contractor specializes in scientific and research services related to the development and...
- This $291,142 firm fixed price prime contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the Institute For Clinical Pharmacodynamics, Inc. to conduct research on updating susceptibility guidance for the oral antibiotics sulfamethoxazole-trimethoprim. The contract supports the agency's efforts to develop modernized susceptibility guidance using pharmacometric approaches. No set-aside designation was used for this award. The Institute For Clinical...
- This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to the Universitat ST. Gallen, doing business as Hochschule FÜR Wirtschafts-, Rechts- UND Sozialwissenschaften (Hsg), an educational institution. The contract is a Firm Fixed Price definitive contract with a potential value of $764,418.19 and a completion date of September 29, 2023. The contract was awarded under the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $505,858.00 Definitive Contract to Uppsala Universitet, an educational institution and state-controlled institution of higher learning, for the "Development of Model-Informed Bioequivalence Evaluation Strategies for Long-Acting Injectable Products." The contract is a Firm Fixed Price agreement without a set-aside designation. Uppsala Universitet will provide scientific and research...
- The Department of Health and Human Services Food and Drug Administration awarded a $1,309,126.30 definitive, cost-no-fee contract to the National Academy of Sciences, a non-profit organization, to conduct a "HORMONES STUDY" with a completion date of September 23, 2020. The contract did not have a set-aside designation. The National Academy of Sciences has a history of providing various research, analysis, advisory, and technical support services to federal agencies through prime and...
- This is a $1,945,000.00 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to Health and Environmental Sciences Institute (HESI), a non-profit organization based in Washington, DC. The contract is for assessing the variability and reproducibility of manual and automated patch clamp platforms, which are used to evaluate drug safety and biological activity. The contract does not have a set-aside designation and has an ultimate completion date of December 31,...
- The Food and Drug Administration (FDA) awarded a $527,318.00 definitive contract to Uppsala Universitet, a Swedish educational institution, to conduct research and development on model-integrated strategies for bioequivalence evaluation of drugs with high variability and/or long half-life. This contract was awarded under the FDA's Broad Agency Announcement, which seeks proposals to advance regulatory science in various areas. The contract has no set-aside designation and is intended to support...
- The federal contract award is for $300,609.00 and was granted to Eurofins Discovery Services North America, LLC, a foreign-owned, for-profit contract research organization. The award is a delivery order under a larger indefinite delivery vehicle (IDV) contract with the National Institute on Drug Abuse (NIDA), a part of the U.S. Department of Health and Human Services. The contract is for receptor profiling and predictive toxicology services, specifically receptor binding studies, safety...
- This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to Florida State University (FSU) as the prime contractor. The $2,277,208 Firm Fixed Price contract was awarded on September 30, 2025 with a completion date of September 29, 2028. It was issued under the FDA's Fiscal Year 2025 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science, which solicits proposals...